Janus Henderson Horizon Biotechnology Fund A2 EUR
LU2441282899
Janus Henderson Horizon Biotechnology Fund A2 EUR/ LU2441282899 /
NAV17/05/2024 |
Chg.+0.0900 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
20.7600EUR |
+0.44% |
reinvestment |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Stratégie d'investissement
The Fund aims to provide capital growth over the long term.
The Fund invests at least 80% of its assets in shares (equities) and equity-related securities of companies, which are biotechnology or biotechnology-related, of any size, including smaller capitalisation companies, in any country. The Fund may also invest in other assets including bonds (including convertible bonds), preference shares, cash and money market instruments. The Investment Manager may use derivatives (complex financial instruments) with the aim of making investment gains in line with the Fund's objective, to reduce risk or to manage the Fund more efficiently.
Objectif d'investissement
The Fund aims to provide capital growth over the long term.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Biotechnology |
Benchmark: |
NASDAQ Biotechnology Total Return Index |
Début de l'exercice: |
01/07 |
Dernière distribution: |
- |
Banque dépositaire: |
BNP Paribas Securities Services, Niederlassung Luxemburg |
Domicile: |
Luxembourg |
Permission de distribution: |
Austria, Germany, Switzerland |
Gestionnaire du fonds: |
Andy Acker, Daniel Lyons, Agustin Mohedas |
Actif net: |
261.8 Mio.
USD
|
Date de lancement: |
25/02/2022 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
5.00% |
Frais d'administration max.: |
1.20% |
Investissement minimum: |
2,500.00 EUR |
Deposit fees: |
0.65% |
Frais de rachat: |
1.00% |
Prospectus simplifié: |
- |
Société de fonds
Société de fonds: |
Janus Henderson Inv. |
Adresse: |
201 Bishopsgate, EC2M 3AE, London |
Pays: |
United Kingdom |
Internet: |
www.janushenderson.com/
|
Actifs
Stocks |
|
97.70% |
Bonds |
|
1.93% |
Cash |
|
0.37% |
Pays
United States of America |
|
67.71% |
United Kingdom |
|
5.07% |
Netherlands |
|
4.51% |
Ireland |
|
3.88% |
Denmark |
|
2.69% |
France |
|
2.44% |
Virgin Islands (British) |
|
2.15% |
China |
|
1.80% |
Cayman Islands |
|
1.16% |
Canada |
|
0.67% |
Cash |
|
0.37% |
Autres |
|
7.55% |
Branches
Pharma/Biotechnology |
|
87.89% |
Healthcare services |
|
1.52% |
Healthcare appliances |
|
0.75% |
Cash |
|
0.37% |
Autres |
|
9.47% |